We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

EOSE:NASDAQEos Energy Enterprises, Inc. Analysis

Data as of 2026-03-31 - not real-time

$4.92

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Eos Energy trades at $4.92, hovering just above the computed support of $4.37 and well below the 20‑day SMA of $5.61, indicating immediate downside pressure. The 30‑day volatility of roughly 173% and a beta of 1.9 underscore a highly volatile, market‑sensitive stock. RSI at 33 places the stock in oversold territory, while the MACD histogram is positive, suggesting a modest short‑term bullish tilt. However, the 200‑day SMA sits near $10.31, far above current levels, confirming a long‑term bearish trend. Fundamental metrics are weak: negative gross margin, operating loss, and a forward PE of –284×, with cash burn exceeding $200 million. The price‑to‑sales ratio of 14.6 is well above the industry average, further highlighting valuation concerns.
Recent material news includes the appointment of Nathaniel Fick to the board, which may improve governance but does not address the underlying cash‑flow deficit. More seriously, multiple securities‑class‑action filings have been issued, citing alleged misstatements of revenue growth and manufacturing timelines. The company also appears on a “12 Most Shorted Stocks to Buy” list, reflecting heightened short‑seller interest and speculative positioning. These legal exposures amplify the already high regulatory risk and could trigger further price volatility. While the upside‑downside metric suggests a 98% upside potential, the combination of negative earnings, high debt, and ongoing litigation makes that upside highly conditional. Investors should therefore treat the stock as a high‑risk, speculative play rather than a stable long‑term holding.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 5/10

Key Factors

  • Oversold RSI indicating potential rebound
  • Positive MACD histogram suggesting short‑term momentum
  • Support level near $4.37 providing downside cushion

Medium Term

1–3 years
Neutral
Model confidence: 4/10

Key Factors

  • Continued negative cash flow and operating losses
  • High volatility and beta increasing price uncertainty
  • Pending securities class‑action litigation

Long Term

> 3 years
Cautious
Model confidence: 7/10

Key Factors

  • Unsustainable business model with negative margins
  • Elevated debt load and weak balance‑sheet metrics
  • High regulatory and legal risk undermining future prospects

Key Metrics & Analysis

Financial Health

Revenue Growth699.60%
P/E Ratio-284.4
ROA-28.10%
P/B Ratio-0.7
Op. Cash Flow$-211190000
Free Cash Flow$-147318624
Industry P/E28.5

Technical Analysis

TrendBearish
RSI33.3
Support$4.37
Resistance$6.97
MA 20$5.61
MA 50$9.74
MA 200$10.31
MACDBullish
VolumeDecreasing
Fear & Greed Index74.84

Valuation

Target Price$9.71
Upside/Downside97.65%
GradeUndervalued
TypeValue

Risk Assessment

Beta1.92
Volatility172.92%
Sector RiskHigh
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.